Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The company’s lead product, the FasTouch system, received FDA clearance in April 2014 for use in minimally invasive and open hernia repairs. Clinical interest has been high due to its ability to provide strong suture-like mesh fixation with less foreign body material than traditional tacks or sutures. The device aims to reduce chronic pain and recurrence rates post-surgery by mimicking traditional sutures while being easier and faster to deploy. No large-scale clinical trial results are published; commercial adoption appears ongoing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Via Surgical.